3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gynecologic
1
Conditions
Weight Loss
1
Uterine Cervical Dysplasia
1
Polycystic Ovary Syndrome
1
Papillomavirus Infections
1
Obesity
1
Insulin Resistance
1
Infertility, Female
1
Infections
1
Interventions
human papillomavirus vaccine, L1 type 16, 18
4
Imiquimod
3
VGX-3100
2
Conization
2
Colposcopy
2
Blood Specimen Collection
2
lime
1
hecolin
1
Vaginal Smears
1
Vaccines, Synthetic
1
Spectrometry, Fluorescence
1
Polymerase Chain Reaction
1
Papillomavirus Vaccines
1
Olive Oil
1
Mass Screening
1
Isotretinoin
1
Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18
1
Hepatitis A Vaccines
1
Fluorouracil
1
Fenretinide
1
Electroporation
1
Cryosurgery
1
AKAP13 protein, human
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 3
×
Uterine Cervical Dysplasia
×
lime
×
Clear all
NCT02346227
2018-10-12
KINVAV
Universiteit Antwerpen
Phase 3
Completed
327 enrolled